Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
9,822 | $4.15 | $40,761 | 797,680 (Indirect Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
2,777 | $4.15 | $11,525 | 42,050 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
2,681 | $4.15 | $11,126 | 375,828 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
3,235 | $4.15 | $13,425 | 37,356 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
3,350 | $4.15 | $13,903 | 47,030 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
2,189 | $4.15 | $9,084 | 25,657 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 4:30 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
555 | $5.64 | $3,130 | 7,255 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-25 Equity Swap |
2025-07-28 5:19 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. GV 2023 GP L.L.C. GV 2023 GP L.P. GV 2023 L.P. Alphabet Inc. 10% Owner |
12,168,489 | $0 | 0 (Indirect) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
12,168,489 | $0 | 0 (Indirect) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
13,280 | $0 | 0 (Direct) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
17,420 | $0 | 0 (Direct) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
700,425 | $0 | 0 (Direct) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
6,952 | $0 | 0 (Direct) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director |
428,326 | $0 | 0 (Indirect) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
348,828 | $0 | 0 (Direct) |
View |
| 2025-07-25 Equity Swap |
2025-07-28 5:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
16,405 | $0 | 0 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:01 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | Cumbo Alexander Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:01 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | COATS LONNEL Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | Morrison Jodie Pope Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | Mikhail Sheila Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | Tatsis Ourania Director |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:00 pm |
N/A 2035-06-04 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
42,200 | $0 | 42,200 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
33,000 | $0 | 797,680 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
18,630 | $0 | 42,050 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
9,000 | $0 | 375,828 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
17,630 | $0 | 37,356 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
11,250 | $0 | 47,030 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
14,680 | $0 | 25,657 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
378,000 | $0 | 378,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
758,000 | $0 | 758,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
265,000 | $0 | 265,000 (Direct) |
View |
| 2024-12-04 Gift |
2024-12-04 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 675,502 (Direct) |
View |
| 2024-11-29 Exercise |
2024-12-03 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,255 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A 2030-09-15 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 1,248,430 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $2.87 | 1,248,430 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Mikhail Sheila Director |
136,139 | $0 | 136,139 (Direct) |
View |